SHANGHAI, Jan. 12 (Xinhua) — A team of Chinese and Singaporean scientists have determined that a type of common immune cell could become an accomplice aiding cancer, and therefore it might be useful to target it in a potential anti-cancer therapy.
Neutrophils, the most abundant white blood cell population in the body and which serve as first responders to infection and injury and also tend to gather around tumo